Alzheimer's disease (AD) is a progressive multifaceted neurodegenerative disease and
remains a formidable global health challenge. The current medication for AD gives …

Alzheimer's disease (AD) is the most prevalent neurodegenerative dementia, marked by
progressive cognitive decline and memory impairment. Despite advances in therapeutic …

Abstract Chalcones (α-phenyl-β-benzoylethylene) and their natural-source derivatives have
been investigated for their remarkable biological activities, like neuroprotective, anti …

Pseudomonas aeruginosa (P. aeruginosa) infection is becoming a severe health hazard
and needs early diagnosis with high specificity. However, the non-specific binding of a …

Numerous neurological disorders, including prion, Parkinson's, and Alzheimer's disease
(AD), are identified as being caused by alterations in protein conformation, aggregation, and …

Alzheimer's disease (AD) remains a significant healthcare challenge, necessitating
innovative therapeutic approaches to address its complex and multifactorial nature …

The inhibition of amyloid-β (Aβ) fibrillation and clearance of Aβ aggregates have emerged
as a potential pharmacological strategy to alleviate Aβ aggregate-induced neurotoxicity in …

Aberrant protein misfolding and accumulation is considered to be a major pathological pillar
of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases …

An effective therapeutic strategy to suppress Alzheimer's disease (AD) progression is to
disrupt β‐sheet rich neurotoxic soluble amyloid‐β (Aβ) aggregates. Previously, we identified …

The ability for amino acid residues to bind metals underpins the functions of metalloproteins
to conduct a plethora of critical processes in living organisms as well as unnatural …